These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8273600)

  • 21. Structure-based design of inhibitors of purine nucleoside phosphorylase. 3. 9-Arylmethyl derivatives of 9-deazaguanine substituted on the methylene group.
    Erion MD; Niwas S; Rose JD; Ananthan S; Allen M; Secrist JA; Babu YS; Bugg CE; Guida WC; Ealick SE
    J Med Chem; 1993 Nov; 36(24):3771-83. PubMed ID: 8254607
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis of 8-amino-3-deazaguanine via imidazole precursors. Antitumor activity and inhibition of purine nucleoside phosphorylase.
    Berry DA; Gilbertsen RB; Cook PD
    J Med Chem; 1986 Oct; 29(10):2034-7. PubMed ID: 3093681
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro study of BCX-34: a new human T-lymphocyte-specific purine phosphorylase inhibitor.
    Iwata H; Wada Y; Walsh M; Montgomery JA; Hirose H; Mendez R; Cicciarelli J; Iwaki Y
    Transplant Proc; 1998 Jun; 30(4):983-6. PubMed ID: 9636397
    [No Abstract]   [Full Text] [Related]  

  • 24. Inhibitors of the enzyme purine nucleoside phosphorylase as potential therapy for psoriasis.
    Morris PE; Omura GA
    Curr Pharm Des; 2000 Jun; 6(9):943-59. PubMed ID: 10828318
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Purine nucleoside phosphorylase inhibitor BCX-1777 (Immucillin-H)--a novel potent and orally active immunosuppressive agent.
    Bantia S; Miller PJ; Parker CD; Ananth SL; Horn LL; Kilpatrick JM; Morris PE; Hutchison TL; Montgomery JA; Sandhu JS
    Int Immunopharmacol; 2001 Jun; 1(6):1199-210. PubMed ID: 11407314
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structure-based design of inhibitors of purine nucleoside phosphorylase. 1. 9-(arylmethyl) derivatives of 9-deazaguanine.
    Montgomery JA; Niwas S; Rose JD; Secrist JA; Babu YS; Bugg CE; Erion MD; Guida WC; Ealick SE
    J Med Chem; 1993 Jan; 36(1):55-69. PubMed ID: 8421291
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics and pharmacodynamics of peldesine (BCX-34), a purine nucleoside phosphorylase inhibitor, following single and multiple oral doses in healthy volunteers.
    Viegas TX; Omura GA; Stoltz RR; Kisicki J
    J Clin Pharmacol; 2000 Apr; 40(4):410-20. PubMed ID: 10761169
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of 9-benzyl-9-deazaguanine, a potent inhibitor of purine nucleoside phosphorylase, on the cytotoxicity and metabolism of 6-thio-2'-deoxyguanosine.
    Parker WB; Allan PW; Niwas S; Montgomery JA; Bennett LL
    Cancer Res; 1994 Apr; 54(7):1742-5. PubMed ID: 8137289
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanisms of deoxyguanosine lymphotoxicity. Human thymocytes, but not peripheral blood lymphocytes accumulate deoxy-GTP in conditions simulating purine nucleoside phosphorylase deficiency.
    Fairbanks LD; Taddeo A; Duley JA; Simmonds HA
    J Immunol; 1990 Jan; 144(2):485-91. PubMed ID: 2104895
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nucleosides. 5. Synthesis of guanine and formycin B derivatives as potential inhibitors of purine nucleoside phosphorylase.
    Chern JW; Lee HY; Chen CS; Shewach DS; Daddona PE; Townsend LB
    J Med Chem; 1993 Apr; 36(8):1024-31. PubMed ID: 8478902
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics/pharmacodynamics of CI-1000, a purine nucleoside phosphorylase (PNP) inhibitor, in rats and monkeys.
    Hallak H; Hayes A; Dong M; Gilbertsen R; Guttendorf R
    Adv Exp Med Biol; 1994; 370():161-5. PubMed ID: 7660882
    [No Abstract]   [Full Text] [Related]  

  • 32. BCX-34: a novel T-cell selective immunosuppressant: purine nucleoside phosphorylase (PNP) inhibitor.
    Wada Y; Yagihashi A; Terasawa K; Miyao N; Hirata K; Cicciarelli J; Iwaki Y
    Artif Organs; 1996 Aug; 20(8):849-52. PubMed ID: 8853794
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 8-Aminoguanine Induces Diuresis, Natriuresis, and Glucosuria by Inhibiting Purine Nucleoside Phosphorylase and Reduces Potassium Excretion by Inhibiting Rac1.
    Jackson EK; Mi Z; Kleyman TR; Cheng D
    J Am Heart Assoc; 2018 Nov; 7(21):e010085. PubMed ID: 30608204
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibitors of purine nucleoside phosphorylase, C(8) and C(5') substitutions.
    Stoeckler JD; Cambor C; Kuhns V; Chu SH; Parks RE
    Biochem Pharmacol; 1982 Jan; 31(2):163-71. PubMed ID: 6800381
    [No Abstract]   [Full Text] [Related]  

  • 35. Purine nucleoside phosphorylase as a cytosolic arsenate reductase.
    Gregus Z; Németi B
    Toxicol Sci; 2002 Nov; 70(1):13-9. PubMed ID: 12388830
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fluorescence studies of calf spleen purine nucleoside phosphorylase (PNP) complexes with guanine and 9-deazaguanine.
    Stepniak K; Zinić B; Wierzchowski J; Bzowska A
    Nucleosides Nucleotides Nucleic Acids; 2007; 26(6-7):841-7. PubMed ID: 18066911
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential cytotoxicity of deoxyguanosine and 8-aminoguanosine for human leukemic cell lines and normal bone marrow progenitor cells.
    de Fouw NJ; Ma DD; Michalevicz R; Gray DA; Hoffbrand AV
    Hematol Oncol; 1984; 2(2):189-97. PubMed ID: 6430777
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The mechanism of inhibition and "reversal" of mitogen-induced lymphocyte activation in a model of purine-nucleoside phosphorylase deficiency.
    Albert D; Bluestein HG; Willis RC; Nette K; Seegmiller JE
    Cell Immunol; 1984 Jul; 86(2):501-9. PubMed ID: 6428752
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of deoxyguanosine on human lymphocyte function. I. Analysis of the interference with lymphocyte proliferation in vitro.
    Spaapen LJ; Rijkers GT; Staal GE; Rijksen G; Wadman SK; Stoop JW; Zegers BJ
    J Immunol; 1984 May; 132(5):2311-7. PubMed ID: 6425399
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and biological evaluation of 9-deazaguanine derivatives connected by a linker to difluoromethylene phosphonic acid as multi-substrate analogue inhibitors of PNP.
    Hikishima S; Hashimoto M; Magnowska L; Bzowska A; Yokomatsu T
    Bioorg Med Chem Lett; 2007 Aug; 17(15):4173-7. PubMed ID: 17544667
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.